Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FX06 for ischemia reperfusion injury in STEMI
NCT00326976Phase 2Completed
- Sponsor
- Fibrex Medical Inc.
- Start
- Aug 2006
- Countries
- 11
01
Overview
A Phase 2 trial of FX06 in myocardial infarction (MI), ischemia-reperfusion injury (IRI), sponsored by Fibrex Medical Inc.. Started Aug 2006; status: completed.
02
Drugs
FX06
03
Conditions
myocardial infarction (MI)ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT00326976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00326976.